What's New This Year?
The Pharma IQ team have listened to your feedback and have restructured the conference format to benefit you. Join us for the 2026 edition of Pharma Contract Manufacturing, where you will engage with industry leaders, experts, and innovators together from the CMO/CDMO and pharmaceutical industry, to participate in meaningful discussions and share best practices.
The session topics covered will surround the challenges of today:
- Market Growth: Learn how the global CMO/CDMO market is set to hit $289.68 billion by 2032, driven by biologics and personalised medicine.
- Regional Trends: Including why North America leads with over 40% market share and Asia-Pacific shows the fastest growth.
- Innovation Drivers: Such as AI, Internet of Things and continuous manufacturing, and how they are transforming efficiency.
- Strategic Partnerships: Explore why long-term Pharma-CDMO alliances and digital integration are essential for resilience and agility.
Why This Event Is Different
Roundtables
Join small, discussion-driven sessions that encourage knowledge sharing, debate, and collaborative problem-solving with peers and experts.
Lightning Sessions
Fast-paced, focused presentations that deliver key insights and innovations in a concise format, perfect for staying ahead of industry trends.
Speed Networking
Connect with a wide range of industry professionals in brief, structured meetings designed to maximise meaningful conversations and new contacts.
Interactive Polling
Engage with live polls throughout sessions, giving you the opportunity to share your insights and see real-time perspectives from fellow attendees.
Read our latest report to stay ahead of the pressures reshaping pharma contract manufacturing
Market Report: Understanding the Future of the
Pharma Contract Manufacturing Industry 2026
Who you will meet
Download our sample 2026 attendee list to see who is joining us so far!
Daiichi Sankyo Europe
Genentech
Merck
Roche
Sandoz
Theramex
Grünenthal
This workshop will unpack the economic architecture behind CMO pricing, from cost structures and profitability measurements to the strategic decisions that ripple across the pharma landscape.
Join us to discuss the best practices that distinguish pharma companies who simply manage suppliers from those who cultivate value-creating alliances
Sandoz Supplier Network Transformation
Whether you are refining your own supplier strategy or simply curious about large-scale transformation, this session offers actionable insights, practical takeaways, and inspiration.
This session will explore how pharma and CMOs can move beyond a traditional “buyer–vendor” relationship toward a shared-risk, shared reward partnership built on co-investment.
Gain valuable insights into the current geopolitical and CDMO landscape, enabling you to identify potential risks and capitalise on emerging opportunities.
Explore dual sourcing and splitting molecule production, focusing on four key dimensions: risk management, regulatory compliance, operational execution, and business strategy.
In Partnership With:
QUESTIONS?
Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: +44 (0) 1135 210 042
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk
©2025 IQPC. All rights reserved.
